Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s Disease
Alzheimer’s disease (AD) is characterized by extracellular accumulation of amyloid-β peptide (Aβ), generated by proteolytic processing of the amyloid precursor protein (APP) by β- and γ-secretase. Aβ generation is inhibited when the initial ectodomain shedding is caused by α-secretase, cleaving APP...
Main Authors: | Heike S. Grimm, Tobias Hartmann, Johannes Lehmann, Benjamin Hundsdörfer, Sven Grösgen, Valerie C. Zimmer, Tatjana L. Rothhaar, Viola J. Haupenthal, Marcus O. W. Grimm |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/3/5879 |
Similar Items
-
α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
by: Pablo Agüero, et al.
Published: (2020-10-01) -
The Role of Cholesterol in Amyloidogenic Substrate Binding to the γ-Secretase Complex
by: Urszula Orzeł, et al.
Published: (2021-06-01) -
APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression
by: Marcus Otto Grimm, et al.
Published: (2015-05-01) -
Plasmalogens Inhibit APP Processing by Directly Affecting γ-Secretase Activity in Alzheimer’s Disease
by: Tatjana L. Rothhaar, et al.
Published: (2012-01-01) -
Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer’s Disease
by: Marcus O. W. Grimm, et al.
Published: (2016-10-01)